INDIANAPOLIS — We are learning more details about the moments leading up to the death of long-time Indianapolis taxi driver Abdukadir Filanwaa.
Filanwaa, 55, was pronounced dead at the scene by medics after they responded to a report of a person shot about 4 a.m. on Sept. 10 near 11th Street and New Jersey Street.
James Riley, 30, and Alysianna Martin, 29, are charged with murder for their alleged involvement.
According to court documents, video from inside the cab captures Riley and Martin entering the cab. Shortly after, Riley pulls a gun and places it against Filanwaa.
Filanwaa then begins driving to the location that Riley tells him, according to court documents.
Court documents allege, during the drive, Riley shows frustration with Filanwaa and asks him multiple times “Do you wanna die?”.
When the cab stops, Riley asks Filanwaa to turn off the cab lights. According to court docs, this is when Riley shoots Filanwaa multiple times.
After their arrest, Riley admitted to police that he shot Filanwaa because of a “misunderstanding”.
Martin is charged with murder, robbery and kidnapping.
Riley is charged with murder, robbery resulting in serious bodily injury, kidnapping and unlawful possession of a firearm by a serious violent felon.
-
Gun rights, sports bans, tariffs — key Supreme Court rulings on the horizon
From tariffs to gun rights to sports bans, the U.S. Supreme Court’s decisions this term could reshape interpretations of the Constitution on personal rights and presidential power.
Zedd returns to headline 2026 Indy 500 Snake Pit
Electronic superstar Zedd is coming back to Indianapolis Motor Speedway, set to headline the 2026 Indy 500 Coors Light Snake Pit.
Bill that could bring Chicago Bears to Indiana advances in House committee
The Chicago Bears moved closer to relocating to Indiana Thursday as a House committee unanimously passed legislation creating the framework to finance a new NFL stadium in Hammond.
FDA to drop two-study requirement for new drug approvals, aiming to speed access
The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs.
